top of page
MANNKIND: AFREZZA — Inhalation Insulin
FDA approved to launch in January 2015. Development included positioning, branding, packaging, website, tradeshow booths and other launch materials.
PHARMACEUTICALS
bottom of page
MANNKIND: AFREZZA — Inhalation Insulin
FDA approved to launch in January 2015. Development included positioning, branding, packaging, website, tradeshow booths and other launch materials.